INFORMATION BY CANCER TYPE
Head and neck
There is a need to find biomarkers that may help predict recurrence in HPV+ oropharyngeal cancer, says Matthew E. Spector, M.D.
From publications to one-on-one interactions, SPOHNC offers caregivers, patients and survivors of oral, head and neck cancer support they need to navigate their diagnosis.
CURE spoke with Carly O’Brien about some of the best tips and resources to deal with some of the challenges of head and neck cancer.
Immunotherapy agents are drastically changing the treatment landscape – and outcomes – of patients with head and neck cancers.
A four-step approach proved to be beneficial in offering psychosocial support to patients with head and neck cancer.
President Barack Obama signed the 21st Century Cures Act into law, allocating more than $6 billion for precision medicine, research, drug abuse prevention and mental health over the next decade.
Nurses at the Cleveland Clinic are pushing to make survivorship care the norm for survivors of head and neck cancer.
Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.
A panel of experts recently discussed the evolving field of immunotherapy for solid tumor types.
The combination of lirilumab Opdivo proved to be effective for a subet of patients with head and neck cancer, according to a recent study.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)
[ Patients ]
Expert-reviewed information summary about oral complications, such as mucositis and salivary gland dysfunction, that occur in cancer patients treated with chemotherapy or radiation therapy to the head and neck.